When caloric intake is substantially reduceda common occurrence given semaglutide's potent effects on appetite and satietythe body shifts from primarily using glucose for energy to breaking down stored fat
A knowledgeable provider can help minimize side effects through proper dosing and monitoring
Tirzepatide deep-dive Tirzepatide is made by Eli Lilly under two brand names: Mounjaro -- weekly injection, FDA-approved for type 2 diabetes in 2022 (doses 2.5 mg through 15 mg) Zepbound -- weekly injection, FDA-approved for chronic weight management in November 2023 [4] The headline trial is SURMOUNT-1: 2,539 adults without diabetes, BMI of 30 or higher (or 27 with a weight-related condition), randomized across three tirzepatide doses (5, 10, 15 mg) versus placebo for 72 weeks
If you have any questions or need assistance, dont hesitate to reach out to: [email protected] Compounded tirzepatide is a personalized medication prepared by a licensed U.S
Monitor your blood glucose levels regularly, especially if you have diabetes and are taking other glucose-lowering medications alongside semaglutide
It was launched in June 2025, which makes it the newest provider in this guide
